Charlottesville, VA—Feb 8, 2018— BrightSpec announced today the sale of a BrightSpec MRR Discovery K-band spectrometer to University of Texas Rio Grande Valley. The instrument is intended for both fundamental research and educational use.
The patented BrightSpec Discovery™ series of instruments utilize an open, reconfigurable form factor to allow research chemists to integrate custom sample chambers, including pulsed and continuous wave jet flows, for studies of molecular complexes and chemical dynamics. The instrument can also be configured for cross-technique analyses using other types of spectroscopy. The Discovery K-band covers the 18-26 GHz frequency range and includes the BrightSpec Edgar™ software suite for experiment setup, data visualization and processing, and spectral library comparison.
The ease-of-use and extensive analytical chemistry capabilities of the BrightSpec Discovery K-Band spectrometer make it suitable for undergraduate and graduate programs where molecular rotational resonance (MRR) will be taught along with traditional spectroscopy techniques. There are currently more than 110 research groups around the world working in MRR spectroscopy. The addition of UTRGV adds one more.
For industrial applications, typical MRR detection level in a 60 second measurement time are in low parts per million (ppm). BrightSpec is the first to offer commercial MRR instruments for trace level chemical analysis. The technique avoids the need for traditional chromatographic separation stages or sample preparation. The Discovery series complements the existing BrightSpec instruments for commercial applications in pharmaceutical discovery, development and process control.
About BrightSpec, Inc.
BrightSpec delivers solutions for identification, quantification and structure analysis of complex chemical mixtures for applications in R&D, pharmaceuticals, fine chemicals, food, and advanced manufacturing sectors. BrightSpec received research funding from the US ARMY and the National Science Foundation, and the Virginia BioHealth Research Corporation. For more information, please contact Justin Neill (CTO) or Bob Lloyd (CEO) at 434-202-2391, or visit www.brightspec.com.